introduction
The “Severe Acute Respiratory
Syndrome Coronavirus 2” 1
(SARS-CoV-2) potentially causes fatal disease named “Covid-19” 2 . The
Incubation period is between 2 days to 2 weeks after being exposed to
the virus3 .
Most common clinical manifestations at the onset of disease include
rhinorrhea, fever, cough, headache and myalgia. SARS-COV-2 seems to have
particular affinity with nervous system; manifestations like hyposmia
and hypogeusia are pathognomonic4.
In more severe cases, individuals may require hospitalization and even
admission into the intensive unit care because the disease may
unexpectedly cause different complications like Acute Respiratory
Distress Syndrome (ARDS), which eventually may lead to death in a short
time5.
Pregnant women represent a patient population vulnerable to covid 19
virus infection due to their reduced immune defense. They are a
challenge for anesthesiological management6,7,8.
Many strategies were performed to reduce the virus spread but the
Covid-19 vaccine is certainly the most effective weapon.
The nucleic acid-genetic approach is a new way of developing vaccines.
Before the COVID-19 pandemic. Because of the pandemic, the research in
this area has progressed very fast and some mRNA vaccines for COVID-19
are getting emergency use authorization9.
Like any vaccine, COVID-19 vaccines can cause side effects, most of
which are mild or moderate and vanish within a few days on their own.
Typical side effects include pain at the injection site, fever, fatigue,
headache, muscle pain, chills and diarrhea, even though more serious or
long-lasting side effects are possible. National authorities and
international bodies, including World Health Organization (WHO), are
closely monitoring for any unexpected side effects following COVID-19
vaccine us9.
The aim of our case report is to present
a rare post-vaccine side effect
like Guillian Barré Syndrome (GBS).